Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yamazaki, H.
Right arrow Articles by Shimada, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, H.
Right arrow Articles by Shimada, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes

Hiroshi Yamazaki, Yukiharu Inui 1, Steven A. Wrighton 2, F.Peter Guengerich 3 and Tsutomu Shimada 4

Osaka Prefectural Institute of Public Health 3-69 Nakamichi 1-chome, Higashinan-ku, Osaka 537, Japan
1Center for Adult Diseases Osaka Higashinari-ku, Osaka 537, Japan
2Department of Drug Metabolism and Disposition, Eli Lilly and Company Indianapolis, IN 46285
3Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine Nashville, TN 37232, USA

4To whom reprint requests should be addressed

Recent studies indicate that cytochrome P450 (P450) 3A4 plays important roles in the activation of procarcinogens such as aflatoxin B1 and sterigmatocystin, as well as in the oxidation of a number of structurally diverse chemicals and endogenous compounds. Since P450 3A5 has been reported to be present at significant levels in liver microsomes in ~25% of human adults, we examined and compared the role of P450 3A4 and 3A5 in procarcinogen activation in humans. Immunoblot experiments with liver microsomes from 60 human samples suggested that 4/30 Japanese and 4/30 Caucasians contained considerable levels of P450 3A5, although P450 3A4 could be determined at relatively high levels in all of the human samples examined. Good correlation was observed between P450 3A4, but not P450 3A5, levels versus activation of aflatoxin B1 and stergmatocystin in these human samples. Comparisons of the activation of procarcinogens in reconstituted monooxy-genase systems containing modified P450 3A4 and 3A5 enzymes expressed in Escherichia coli were carried out in Salmonella typhimurium TA1535/pSK1002 or NM2009 tester strain for genotoxicity assay, and it was found that P450 3A4 had similar activities to or higher rates than P450 3A5 for the 24 procarcinogens tested.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
K. Gross-Steinmeyer, P. L. Stapleton, J. H. Tracy, T. K. Bammler, S. C. Strom, D. R. Buhler, and D. L. Eaton
Modulation of Aflatoxin B1-Mediated Genotoxicity in Primary Cultures of Human Hepatocytes by Diindolylmethane, Curcumin, and Xanthohumols
Toxicol. Sci., December 1, 2009; 112(2): 303 - 310.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. J. Ronis, Y. Chen, J. Badeaux, E. Laurenzana, and T. M. Badger
Soy Protein Isolate Induces CYP3A1 and CYP3A2 in Prepubertal Rats
Experimental Biology and Medicine, January 1, 2006; 231(1): 60 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Smit, R. H. N. van Schaik, M. van der Werf, A. W. van den Beld, J. W. Koper, J. Lindemans, H. A. P. Pols, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts
A Common Polymorphism in the CYP3A7 Gene Is Associated with a Nearly 50% Reduction in Serum Dehydroepiandrosterone Sulfate Levels
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5313 - 5316.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. Ronis, Y. Chen, C.-H. Jo, P. Simpson, and T. M. Badger
Diets Containing Soy Protein Isolate Increase Hepatic CYP3A Expression and Inducibility in Weanling Male Rats Exposed during Early Development
J. Nutr., December 1, 2004; 134(12): 3270 - 3276.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Hukkanen, T. Vaisanen, A. Lassila, R. Piipari, S. Anttila, O. Pelkonen, H. Raunio, and J. Hakkola
Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived Cells
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 745 - 752.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-F. Yueh, N. Nguyen, M. Famourzadeh, C. P. Strassburg, Y. Oda, F.P. Guengerich, and R. H. Tukey
The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines
Carcinogenesis, June 1, 2001; 22(6): 943 - 950.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. A.J. Schut and E. G. Snyderwine
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Carcinogenesis, March 1, 1999; 20(3): 353 - 368.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.